Skip to main navigation Skip to search Skip to main content

Open-Label Pilot Safety Study of AP-104IVT (Sustained-Release Fluticasone, Intravitreal) after a Single Intravitreal Injection in Patients with Diabetic Macular Edema

Grants and Contracts Details

StatusFinished
Effective start/end date4/10/13 → 7/31/14

Funding

  • Auritec Pharmaceuticals Incorporated: $2.00